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Background: Percutaneous endoscopic gastrostomy (PEG) is often performed for alimentation and to prevent
weight loss in patients with feeding problems due to central neurologic diseases such as cerebral infarction or
intracranial hemorrhage. Although infection at the skin site after PEG placement is a typical late complication of
PEG, a ruptured infectious pseudoaneurysm caused massive bleeding adjacent to the tract is rare. Prompt treatment
is required to avoid the hemorrhage shock, however surgical ligation is difficult to obtain the arrest of bleeding in
damaged skin due to the infection.
Case presentation: A 70-year-old male was bedridden due a cerebral infarction suffered 1 year previously. APEG
was placed because of feeding problems, and a push-type, 20-Fr gastrostomy tube was inserted through the
anterior abdominal wall. On day 16 after PEG placement, the patient had massive bleeding from the PEG site due
to the rupture of infectious pseudoaneurysm and developed a decreased level of consciousness and hypotension.
Treatment by percutaneous direct injection of a mixture of n-butyl-cyanoacrylate (NBCA)-lipiodol was performed
and achieved good hemostasis is obtained.
Conclusions: A rare case of an infectious pseudoaneurysm that developed in the abdominal wall and caused
massive bleeding at a PEG placement site was described. Percutaneous injection of a mixture of n-butyl-cyanoacrylate
(NBCA)-lipiodol under ultrasound guidance is an effective treatment in this case.
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In iatrogenic or infectious pseudoaneurysms due to surgery
or other interventions, and in superficial pseudoaneurysms
due to trauma, the usefulness of surgery, embolization,
ultrasound-guided manual compression, and percutan-
eous thrombin injection has long been reported [1-3].
The usefulness of percutaneous injection of a mixture
of NBCA-lipiodol has also been described in some re-
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reproduction in any medium, provided the orCase presentation
A 70-year-old male was bedridden due a cerebral infarc-
tion suffered 1 year previously. A PEG was placed because
of feeding problems, and a push-type, 20-Fr gastrostomy
tube (Neofeed PEG kit; Top Corporation, Tokyo, Japan)
was inserted through the anterior abdominal wall under
electronic gastroscopy assistance (Olympus GIF 260;
Olympus Corporation, Tokyo, Japan).
CT examination after the placement of gastrostomy
tube shows no abnormal findings around the gastrostomy
site. An alimentation through the PEG tube was started
the next day. About 13 days after PEG feeding was started,
infection with erythema of skin being 60 mm in diame-
terat the PEG site and slight pus drainage from clearancetd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Figure 1 Emergency contrast-enhanced CT after hemorrhagic
shock shows a well-visualized pseudoaneurysm in the right
abdominal wall near the PEG tube site (arrow).
Figure 3 A mixture of NBCA-lipiodol was injected into the
pseudoaneurysm under echo-guidance (arrow). The dash line
indicates the echo-guided puncture line.
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the abscess formation could not be detected. Bacterial
culture of the pus revealed Pseudomonas aeruginosa.
Antibiotics to which the organism was sensitive were
administered, the area was disinfected with povidone-
iodine (Isodine, Meiji Seika Farma, Tokyo, Japan) and pus
was carefully aspirated. Infected wound led to tem-
porary improvement after this treatment. Thus alimenta-
tion using the PEG tube was continued. However, on day
16 after PEG placement, the patient had massive bleeding
from the PEG site and developed a decreased level of con-
sciousness and hypotension.
Peripheral blood tests showed a decrease in hemoglobin
from 10 mg/dL to 6 mg/dL. Hemorrhagic shock from
the PEG site was diagnosed, and an emergency contrast-Figure 2 Color Doppler ultrasonography before injection
therapy shows definite blood flow signal, indicating
infectious pseudoaneurysm.enhanced CT was performed. CT showed a 5-mm, nodu-
lar, enhanced mass in the right abdominal wall near the
PEG tube, and an abdominal wall pseudoaneurysm due to
infection was diagnosed (Figure 1). Temporary hemostasis
was achieved by strong bilateral compression of the
bumper of the abdominal wall and the gastric wall. How-
ever, color Doppler ultrasonography 24 h later showed
blood flow in the pseudoaneurysm, so bumper compres-
sion had not achieved thrombosis (Figure 2).
Therefore, the infectious pseudoaneurysm was directly
punctured with a 21-G needle under ultrasound-guidance,
and 0.4 mL of an NBCA-lipiodol mixture (1:1) was
manually injected (Figure 3). The mixture in the in-
fectious pseudoaneurysm hardened immediately, and
color Doppler ultrasonography showed loss of the blood
flow signal in the infectious pseudoaneurysm. Unenhanced
CT was performed on the next day after treatment, and
a high-density area in the infectious pseudoaneurysm
due to lipiodol accumulation was visualized (Figure 4).Figure 4 Unenhanced CT the next day after treatment shows a
high-density area of lipiodol in the aneurysm (arrow).
Figure 5 Color Doppler usltasonography one week after
treatment shows loss of the blood flow signal, with complete
thrombosis of the aneurysm (arrow).
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Doppler ultrasonography still showed that the infec-
tious pseudoaneurysm was thrombosed without a blood
flow signal (Figure 5). Use of the PEG tube was resumed
2 weeks after treatment, re-bleeding did not occur, the pa-
tient’s general condition improved, and he was discharged
home. All ultrasonographic procedures were performed
with an Xario scanner (Toshiba Medical Systems Corpor-
ation, Tochigi, Japan) and a 3.5-7.5 MHz transducer. This
retrospective study was approved by ethical committee,
and written informed consent was obtained from the pa-
tient before all procedures.
Discussion
Complications associated with percutaneous gastrostomy
tube placement are broadly divided into early complica-
tions due to the procedure, such as bleeding or bowel
perforation during PEG placement, and late complica-
tions, as in the present patient, that occur sometime
after PEG placement [6,7]. Most complications are in-
fections of the skin site, and infections of the PEG tube
site particularly tend to develop in patients with decreased
immunity who are elderly or have poor nutritional status
[6]. Infections may be mild, but abscess formation in the
skin may also occur [8]. The present patient did not
have abscess formation, but infection due to Psedomonas
aeruginosa of the PEG site skin occurred, and togetherwith this, an infectious pseudoaneurysm of the epigastric
artery near the PEG tube developed.
Pseudoaneurysms in the gastric wall after PEG place-
ment have been reported [9], but according to our lit-
erature search, an infectious pseudoaneurysm in the
abdominal wall as in the present case has not been
previously reported. If the infectious pseudoaneurysm
ruptures, as in the present patient, bleeding can be life-
threatening, and treatment such as surgery, embolization,
compression, or percutaneous injection of a blood-
clotting agent like thrombin is necessary [1-3]. Percu-
taneous injection is clearly less invasive than surgery
or embolization, is convenient, and has recently be-
come the treatment of first choice [4,5]. Various types
of clotting agents are used, but when thrombin, which is
the most common, is used, its potent clotting effect can
severely irritate the surrounding tissue, it tends to cause
allergic reactions, and embolization of peripheral vessels
occasionally occurs, which can lead to surrounding tissue
damage [4].
In comparison, with a mixture of NBCA-lipiodol, the
NBCA immediately causes polymerization with sodium
ions in the blood, so blood coagulation occurs immedi-
ately [10,11]. Thus, the blood clotting ability is potent,
and irritation of the surrounding skin is less. Therefore,
this is an appropriate clotting agent in cases of skin in-
fection as in the present patient. In addition, by chan-
ging the NBCA-lipiodol mixture ratio, the clotting time
can be adjusted. With a 1:1 ratio, blood polymerization
and clotting are reported to occur in about 2 to 3 sec-
onds, so selection of a 1:1 mixture ratio in the present
patient led to good results [4,10,11].
Conclusion
A rare case of an infectious pseudoaneurysm that devel-
oped in the abdominal wall and caused massive bleeding at
a PEG placement site was described. Compression of the
bumper was attempted, but it was unsuccessful in achieving
thrombosis. The injection of a mixture of NBCA-lipiodol
into the infectious pseudoaneurysm under ultrasound-
guidance rapidly led to thrombosis and hemostasis. We be-
lieve that this is an effective treatment in this case.
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